VICTOR, NY – November 02, 2026 – PRESSADVANTAGE –

Rejuvn8 Aesthetics, led by Medical Director Dr. Elizabeth Carmichael, MD, announces the official addition of Sculptra® (injectable poly-L-lactic acid) to its full treatment roster at the clinic’s regional office located at 202 High Point Drive, Victor, NY 14564. This service introduction expands the facility’s scope of non-surgical aesthetic modalities, offering patients in the greater Rochester and Finger Lakes regions an evidence-based biostimulatory option designed to address age-related facial volume loss and underlying structural dermal decline.

Sculptra in Rochester, NY is a biocompatible, biodegradable injectable implant formulation containing microparticles of poly-L-lactic acid (PLLA-SCA). Unlike conventional hyaluronic acid (HA) dermal fillers, which act as immediate volume space-occupiers within tissue layers, poly-L-lactic acid functions via a distinct biostimulatory pathway. Upon targeted injection into the deep dermal or subcutaneous plane, the PLLA microparticles initiate a controlled, localized subclinical inflammatory tissue reaction. This metabolic pathway prompts surrounding host fibroblasts to synthesize and deposit new autologous Collagen Type I over subsequent months. As the PLLA microparticles slowly degrade, the newly formed collagen matrix remains, rebuilding structural integrity within the facial matrix.

FDA indications, safety data, and protocol requirements include:

FDA-Approved Indications: Sculptra is FDA-approved for use in immune-competent individuals as a single regimen for the correction of shallow to deep nasolabial fold contour deficiencies and other facial age-related wrinkles. Data from regulatory filings, including the FDA Summary of Safety and Effectiveness Data (SSED), demonstrate that clinical correction is sustained for up to two years (24 months) following completion of a multi-session regimen.

Treatment Regimen & Clinical Protocols: Achieving optimal aesthetic outcomes typically requires a structured series of treatment sessions—most commonly 2 to 3 sessions spaced 4 to 6 weeks apart—depending on the extent of structural tissue atrophy and individual facial anatomy. Clinical outcomes, collagen synthesis capacity, and total duration of effect vary from patient to patient based on physiological factors, age, metabolism, and lifestyle.

Adverse Effects & Safety Profile: In clinical trials evaluated by regulatory authorities, the most common reported treatment-site reactions included temporary injection-site swelling, tenderness, erythema (redness), localized pain, bruising, bleeding, and mild itching. Less common adverse events include the formation of small, non-visible subcutaneous papules or visible nodules within the target treatment site.

Contraindications: Sculptra in Rochester, NY is strictly contraindicated for individuals with known hypersensitivity to poly-L-lactic acid, carboxymethylcellulose, or mannitol. It should not be administered in the presence of active skin inflammation, localized infection, or active skin lesions near the planned injection site, nor should it be used in patients with a history of keloid formation or hypertrophic scarring.

Treatments at Rejuvn8 Aesthetics are administered by Dr. Elizabeth Carmichael and a specialized team of certified medical aesthetic practitioners with over 20 years of combined clinical experience. Every patient candidate undergoes a mandatory baseline facial assessment to evaluate skin elasticity, structural loss, medical history, and individual physiological considerations prior to developing a tailored dosing plan.

“Patients frequently express interest in treatments that address the underlying structural factors of facial aging,” explains Dr. Carmichael. “Integrating poly-L-lactic acid allows us to offer an established biostimulatory protocol that relies on native collagen production to gradually restore structural support over time.”

This progressive approach yields subtle, natural-looking results that develop over several months and can last up to two years. Comprehensive post-treatment evaluations ensure optimal collagen neocollagenesis while maintaining high safety standards. These expanded restorative services are now available to patients across all Rejuvn8 Aesthetics clinical practice locations in Upstate New York.

###

For more information about Rejuvn8 Aesthetics, contact the company here:

Rejuvn8 Aesthetics
Rejuvn8 Aesthetics
315-932-6869
rejuvn8@rejuvn8.com
Victor, NY

Media gallery

About The Author
PressAdvantage